Log in
Enquire now
Delinia

Delinia

Delinia is a biotechnology company that is developing novel therapeutics for treating autoimmune diseases.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
Acquisition Transaction
Acquisition of Delinia by Celgene Corporation
Acquisition of Delinia by Celgene Corporation
B2X
B2B
B2B
Company Operating Status
Active
Crunchbase URL
crunchbase.com/organiz.../delinia
Former CEO
Saurabh Saha MD PhD
Saurabh Saha MD PhD
Founded Date
2015
Founder
Jeffrey Greve
Jeffrey Greve
Industry
Technology
Technology
Autoimmune disease
Autoimmune disease
Therapeutics
Therapeutics
Biotechnology
Biotechnology
Biology
Biology
Investors
Sofinnova Partners
Sofinnova Partners
Atlas Ventures
Atlas Ventures
Latest Funding Round Date
September 14, 2016
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/delinia
Total Funding Amount (USD)
70,000,000
Official Website
deliniabio.com

Find more companies like Delinia

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.